These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 3063853)
1. [Clinical effects of P-100 (CSF-HU) in chronic neutropenia of childhood]. Komiyama A; Ishiguro A; Akabane T; Tsuchida M; Tsukimoto I; Hanawa Y; Higuchi S; Matsuda I; Nakazawa S; Yamamoto M Rinsho Ketsueki; 1988 Sep; 29(9):1365-70. PubMed ID: 3063853 [No Abstract] [Full Text] [Related]
2. Clinical use of GM-CSF in autologous bone marrow transplantation. Carella AM; Gaozza E; Piatti G; Giordano D; Santini G; Carlier P; Raffo MR; Nati AS; Congin A; Bacigalupo A Int J Cell Cloning; 1990 Jan; 8 Suppl 1():279-82. PubMed ID: 2182740 [TBL] [Abstract][Full Text] [Related]
3. The promise of colony-stimulating factors in clinical practice. Glaspy JA; Ambersley JM Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043 [TBL] [Abstract][Full Text] [Related]
4. [A phase II clinical trial of human urinary CSF (P-100) in pediatric patients]. Tsuchida M; Ohara A; Tsukimoto I; Hanawa Y; Akatsuka J; Hoshi Y; Ueda Y; Yamamoto M; Akabane T; Komiyama J Rinsho Ketsueki; 1988 Jul; 29(7):1041-9. PubMed ID: 2460650 [No Abstract] [Full Text] [Related]
5. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials. Nissen-Druey C Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852 [No Abstract] [Full Text] [Related]
6. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. Jakubowski AA; Souza L; Kelly F; Fain K; Budman D; Clarkson B; Bonilla MA; Moore MA; Gabrilove J N Engl J Med; 1989 Jan; 320(1):38-42. PubMed ID: 2462670 [No Abstract] [Full Text] [Related]
7. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595 [TBL] [Abstract][Full Text] [Related]
8. Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Freund MR; Luft S; Schöber C; Heussner P; Schrezenmaier H; Porzsolt F; Welte K Lancet; 1990 Aug; 336(8710):313. PubMed ID: 1695985 [No Abstract] [Full Text] [Related]
9. Transient cyclic neutropenia following GM-CSF in a patient with chronic granulocytic leukemia transplanted with HLA-identical T cell-depleted donor bone marrow. Gluckman E; Socie G; Yver A; Esperou H; Devergie A; Stern A Bone Marrow Transplant; 1989 Sep; 4(5):591-2. PubMed ID: 2676045 [TBL] [Abstract][Full Text] [Related]
10. [GM-CSF: its use in onco-hematologic diseases]. Visani G; Tosi P; Benfenati D; Colombini R; Cenacchi AR; Gamberi B; Lemoli RM; Tura S Haematologica; 1989 Oct; 74(5 Suppl):501-10. PubMed ID: 2512232 [No Abstract] [Full Text] [Related]
11. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R Haematol Blood Transfus; 1990; 33():717-23. PubMed ID: 2182461 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. Nienhuis AW; Donahue RE; Karlsson S; Clark SC; Agricola B; Antinoff N; Pierce JE; Turner P; Anderson WF; Nathan DG J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903 [TBL] [Abstract][Full Text] [Related]
13. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Herrmann F; Schulz G; Wieser M; Kolbe K; Nicolay U; Noack M; Lindemann A; Mertelsmann R Am J Med; 1990 Jun; 88(6):619-24. PubMed ID: 2189305 [TBL] [Abstract][Full Text] [Related]
14. [Agranulocytosis treatment with rhGM-CSF]. Rosien U; Benker G; Brittinger G; Reinwein D Dtsch Med Wochenschr; 1989 Nov; 114(47):1861. PubMed ID: 2684585 [No Abstract] [Full Text] [Related]
15. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. Bonilla MA; Gillio AP; Ruggeiro M; Kernan NA; Brochstein JA; Abboud M; Fumagalli L; Vincent M; Gabrilove JL; Welte K; Souza LM; O'Reilly RJ N Engl J Med; 1989 Jun; 320(24):1574-80. PubMed ID: 2471075 [TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant human granulocyte-macrophage colony-stimulating factor on phagocyte kinetics in man. Linch DC; Devereux S; Addison IE Behring Inst Mitt; 1988 Aug; (83):320-3. PubMed ID: 3071347 [TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure. Antin JH; Smith BR; Holmes W; David RN; Rosenthal S Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331 [TBL] [Abstract][Full Text] [Related]
18. Agranulocytosis associated with T-gamma-lymphocytosis: no improvement of peripheral blood granulocyte count with human-recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Thomssen C; Nissen C; Gratwohl A; Tichelli A; Stern A Br J Haematol; 1989 Jan; 71(1):157-8. PubMed ID: 2644967 [No Abstract] [Full Text] [Related]
19. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis. Champlin RE; Nimer SD; Oette D; Golde DW Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137 [No Abstract] [Full Text] [Related]
20. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity in chronic severe neutropenia. Ganser A; Ottmann OG; Erdmann H; Schulz G; Hoelzer D Ann Intern Med; 1989 Dec; 111(11):887-92. PubMed ID: 2683920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]